COVID-19 Impact on Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2026

COVID-19 Impact on Global Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Bipolar Disorder Therapeutics Drugs Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Olanzapine (Zyprexa)
1.4.3 Quetiapine (Seroquel)
1.4.4 Risperidone (Risperdal)
1.4.5 Ariprazole (Abilify)
1.4.6 Ziprasidone (Geodon)
1.4.7 Clozapine (Clozaril)
1.5 Market by Application
1.5.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 lumateperone
1.5.3 Central Nervous System (CNS) Disorders
1.6 Coronavirus Disease 2019 (Covid-19): Bipolar Disorder Therapeutics Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Bipolar Disorder Therapeutics Drugs Industry
1.6.1.1 Bipolar Disorder Therapeutics Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Bipolar Disorder Therapeutics Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Bipolar Disorder Therapeutics Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Therapeutics Drugs Market Size Estimates and Forecasts
2.1.1 Global Bipolar Disorder Therapeutics Drugs Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Bipolar Disorder Therapeutics Drugs Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Bipolar Disorder Therapeutics Drugs Production Estimates and Forecasts 2015-2026
2.2 Global Bipolar Disorder Therapeutics Drugs Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Bipolar Disorder Therapeutics Drugs Manufacturers Geographical Distribution
2.4 Key Trends for Bipolar Disorder Therapeutics Drugs Markets & Products
2.5 Primary Interviews with Key Bipolar Disorder Therapeutics Drugs Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Production Capacity
3.1.1 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Production (2015-2020)
3.1.3 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers Market Share by Production
3.2 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue
3.2.1 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutics Drugs Revenue in 2019
3.3 Global Bipolar Disorder Therapeutics Drugs Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Therapeutics Drugs Production by Regions
4.1 Global Bipolar Disorder Therapeutics Drugs Historic Market Facts & Figures by Regions
4.1.1 Global Top Bipolar Disorder Therapeutics Drugs Regions by Production (2015-2020)
4.1.2 Global Top Bipolar Disorder Therapeutics Drugs Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Bipolar Disorder Therapeutics Drugs Production (2015-2020)
4.2.2 North America Bipolar Disorder Therapeutics Drugs Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Bipolar Disorder Therapeutics Drugs Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Bipolar Disorder Therapeutics Drugs Production (2015-2020)
4.3.2 Europe Bipolar Disorder Therapeutics Drugs Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Bipolar Disorder Therapeutics Drugs Import & Export (2015-2020)
4.4 China
4.4.1 China Bipolar Disorder Therapeutics Drugs Production (2015-2020)
4.4.2 China Bipolar Disorder Therapeutics Drugs Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Bipolar Disorder Therapeutics Drugs Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Bipolar Disorder Therapeutics Drugs Production (2015-2020)
4.5.2 Japan Bipolar Disorder Therapeutics Drugs Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Bipolar Disorder Therapeutics Drugs Import & Export (2015-2020)
5 Bipolar Disorder Therapeutics Drugs Consumption by Region
5.1 Global Top Bipolar Disorder Therapeutics Drugs Regions by Consumption
5.1.1 Global Top Bipolar Disorder Therapeutics Drugs Regions by Consumption (2015-2020)
5.1.2 Global Top Bipolar Disorder Therapeutics Drugs Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Bipolar Disorder Therapeutics Drugs Consumption by Application
5.2.2 North America Bipolar Disorder Therapeutics Drugs Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Bipolar Disorder Therapeutics Drugs Consumption by Application
5.3.2 Europe Bipolar Disorder Therapeutics Drugs Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Application
5.4.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Application
5.5.2 Central & South America Bipolar Disorder Therapeutics Drugs Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Application
5.6.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Type (2015-2020)
6.1.1 Global Bipolar Disorder Therapeutics Drugs Production by Type (2015-2020)
6.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2015-2020)
6.1.3 Bipolar Disorder Therapeutics Drugs Price by Type (2015-2020)
6.2 Global Bipolar Disorder Therapeutics Drugs Market Forecast by Type (2021-2026)
6.2.1 Global Bipolar Disorder Therapeutics Drugs Production Forecast by Type (2021-2026)
6.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2021-2026)
6.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2021-2026)
6.3 Global Bipolar Disorder Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Bipolar Disorder Therapeutics Drugs Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Corporation Information
8.1.2 AstraZeneca Overview and Its Total Revenue
8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 AstraZeneca Product Description
8.1.5 AstraZeneca Recent Development
8.2 Allergan
8.2.1 Allergan Corporation Information
8.2.2 Allergan Overview and Its Total Revenue
8.2.3 Allergan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Allergan Product Description
8.2.5 Allergan Recent Development
8.3 Bristol-Myers Squibb
8.3.1 Bristol-Myers Squibb Corporation Information
8.3.2 Bristol-Myers Squibb Overview and Its Total Revenue
8.3.3 Bristol-Myers Squibb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Bristol-Myers Squibb Product Description
8.3.5 Bristol-Myers Squibb Recent Development
8.4 GSK
8.4.1 GSK Corporation Information
8.4.2 GSK Overview and Its Total Revenue
8.4.3 GSK Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 GSK Product Description
8.4.5 GSK Recent Development
8.5 Janssen
8.5.1 Janssen Corporation Information
8.5.2 Janssen Overview and Its Total Revenue
8.5.3 Janssen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Janssen Product Description
8.5.5 Janssen Recent Development
8.6 AbbVie
8.6.1 AbbVie Corporation Information
8.6.2 AbbVie Overview and Its Total Revenue
8.6.3 AbbVie Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 AbbVie Product Description
8.6.5 AbbVie Recent Development
8.7 Youdim
8.7.1 Youdim Corporation Information
8.7.2 Youdim Overview and Its Total Revenue
8.7.3 Youdim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Youdim Product Description
8.7.5 Youdim Recent Development
8.8 Delpor
8.8.1 Delpor Corporation Information
8.8.2 Delpor Overview and Its Total Revenue
8.8.3 Delpor Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Delpor Product Description
8.8.5 Delpor Recent Development
8.9 Lundbeck
8.9.1 Lundbeck Corporation Information
8.9.2 Lundbeck Overview and Its Total Revenue
8.9.3 Lundbeck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Lundbeck Product Description
8.9.5 Lundbeck Recent Development
8.10 Intra-Cellular Therapies
8.10.1 Intra-Cellular Therapies Corporation Information
8.10.2 Intra-Cellular Therapies Overview and Its Total Revenue
8.10.3 Intra-Cellular Therapies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Intra-Cellular Therapies Product Description
8.10.5 Intra-Cellular Therapies Recent Development
8.11 Novartis Pharmaceuticals Corporation
8.11.1 Novartis Pharmaceuticals Corporation Corporation Information
8.11.2 Novartis Pharmaceuticals Corporation Overview and Its Total Revenue
8.11.3 Novartis Pharmaceuticals Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Novartis Pharmaceuticals Corporation Product Description
8.11.5 Novartis Pharmaceuticals Corporation Recent Development
8.12 Noven Pharmaceuticals
8.12.1 Noven Pharmaceuticals Corporation Information
8.12.2 Noven Pharmaceuticals Overview and Its Total Revenue
8.12.3 Noven Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Noven Pharmaceuticals Product Description
8.12.5 Noven Pharmaceuticals Recent Development
8.13 Otsuka
8.13.1 Otsuka Corporation Information
8.13.2 Otsuka Overview and Its Total Revenue
8.13.3 Otsuka Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Otsuka Product Description
8.13.5 Otsuka Recent Development
8.14 Pfizer
8.14.1 Pfizer Corporation Information
8.14.2 Pfizer Overview and Its Total Revenue
8.14.3 Pfizer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Pfizer Product Description
8.14.5 Pfizer Recent Development
8.15 Reviva Pharmaceuticals
8.15.1 Reviva Pharmaceuticals Corporation Information
8.15.2 Reviva Pharmaceuticals Overview and Its Total Revenue
8.15.3 Reviva Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Reviva Pharmaceuticals Product Description
8.15.5 Reviva Pharmaceuticals Recent Development
9 Production Forecasts by Regions
9.1 Global Top Bipolar Disorder Therapeutics Drugs Regions Forecast by Revenue (2021-2026)
9.2 Global Top Bipolar Disorder Therapeutics Drugs Regions Forecast by Production (2021-2026)
9.3 Key Bipolar Disorder Therapeutics Drugs Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region
10.1 Global Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
10.2 North America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
10.3 Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
10.5 Latin America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Bipolar Disorder Therapeutics Drugs Sales Channels
11.2.2 Bipolar Disorder Therapeutics Drugs Distributors
11.3 Bipolar Disorder Therapeutics Drugs Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Bipolar Disorder Therapeutics Drugs Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Bipolar Disorder Therapeutics Drugs Key Market Segments in This Study
Table 2. Ranking of Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Olanzapine (Zyprexa)
Table 5. Major Manufacturers of Quetiapine (Seroquel)
Table 6. Major Manufacturers of Risperidone (Risperdal)
Table 7. Major Manufacturers of Ariprazole (Abilify)
Table 8. Major Manufacturers of Ziprasidone (Geodon)
Table 9. Major Manufacturers of Clozapine (Clozaril)
Table 10. COVID-19 Impact Global Market: (Four Bipolar Disorder Therapeutics Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Bipolar Disorder Therapeutics Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Bipolar Disorder Therapeutics Drugs Players to Combat Covid-19 Impact
Table 15. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global Bipolar Disorder Therapeutics Drugs Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 17. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2019)
Table 19. Bipolar Disorder Therapeutics Drugs Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Bipolar Disorder Therapeutics Drugs Product Offered
Table 21. Date of Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
Table 22. Key Trends for Bipolar Disorder Therapeutics Drugs Markets & Products
Table 23. Main Points Interviewed from Key Bipolar Disorder Therapeutics Drugs Players
Table 24. Global Bipolar Disorder Therapeutics Drugs Production Capacity by Manufacturers (2015-2020) (K Units)
Table 25. Global Bipolar Disorder Therapeutics Drugs Production Share by Manufacturers (2015-2020)
Table 26. Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 27. Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 28. Bipolar Disorder Therapeutics Drugs Price by Manufacturers 2015-2020 (USD/Unit)
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Bipolar Disorder Therapeutics Drugs Production by Regions (2015-2020) (K Units)
Table 31. Global Bipolar Disorder Therapeutics Drugs Production Market Share by Regions (2015-2020)
Table 32. Global Bipolar Disorder Therapeutics Drugs Revenue by Regions (2015-2020) (US$ Million)
Table 33. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Table 34. Key Bipolar Disorder Therapeutics Drugs Players in North America
Table 35. Import & Export of Bipolar Disorder Therapeutics Drugs in North America (K Units)
Table 36. Key Bipolar Disorder Therapeutics Drugs Players in Europe
Table 37. Import & Export of Bipolar Disorder Therapeutics Drugs in Europe (K Units)
Table 38. Key Bipolar Disorder Therapeutics Drugs Players in China
Table 39. Import & Export of Bipolar Disorder Therapeutics Drugs in China (K Units)
Table 40. Key Bipolar Disorder Therapeutics Drugs Players in Japan
Table 41. Import & Export of Bipolar Disorder Therapeutics Drugs in Japan (K Units)
Table 42. Global Bipolar Disorder Therapeutics Drugs Consumption by Regions (2015-2020) (K Units)
Table 43. Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions (2015-2020)
Table 44. North America Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 45. North America Bipolar Disorder Therapeutics Drugs Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 47. Europe Bipolar Disorder Therapeutics Drugs Consumption by Countries (2015-2020) (K Units)
Table 48. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 49. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application (2015-2020) (K Units)
Table 50. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption by Regions (2015-2020) (K Units)
Table 51. Latin America Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 52. Latin America Bipolar Disorder Therapeutics Drugs Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 54. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption by Countries (2015-2020) (K Units)
Table 55. Global Bipolar Disorder Therapeutics Drugs Production by Type (2015-2020) (K Units)
Table 56. Global Bipolar Disorder Therapeutics Drugs Production Share by Type (2015-2020)
Table 57. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2015-2020) (Million US$)
Table 58. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 59. Bipolar Disorder Therapeutics Drugs Price by Type 2015-2020 (USD/Unit)
Table 60. Global Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 61. Global Bipolar Disorder Therapeutics Drugs Consumption by Application (2015-2020) (K Units)
Table 62. Global Bipolar Disorder Therapeutics Drugs Consumption Share by Application (2015-2020)
Table 63. AstraZeneca Corporation Information
Table 64. AstraZeneca Description and Major Businesses
Table 65. AstraZeneca Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. AstraZeneca Product
Table 67. AstraZeneca Recent Development
Table 68. Allergan Corporation Information
Table 69. Allergan Description and Major Businesses
Table 70. Allergan Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Allergan Product
Table 72. Allergan Recent Development
Table 73. Bristol-Myers Squibb Corporation Information
Table 74. Bristol-Myers Squibb Description and Major Businesses
Table 75. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Bristol-Myers Squibb Product
Table 77. Bristol-Myers Squibb Recent Development
Table 78. GSK Corporation Information
Table 79. GSK Description and Major Businesses
Table 80. GSK Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. GSK Product
Table 82. GSK Recent Development
Table 83. Janssen Corporation Information
Table 84. Janssen Description and Major Businesses
Table 85. Janssen Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Janssen Product
Table 87. Janssen Recent Development
Table 88. AbbVie Corporation Information
Table 89. AbbVie Description and Major Businesses
Table 90. AbbVie Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. AbbVie Product
Table 92. AbbVie Recent Development
Table 93. Youdim Corporation Information
Table 94. Youdim Description and Major Businesses
Table 95. Youdim Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Youdim Product
Table 97. Youdim Recent Development
Table 98. Delpor Corporation Information
Table 99. Delpor Description and Major Businesses
Table 100. Delpor Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Delpor Product
Table 102. Delpor Recent Development
Table 103. Lundbeck Corporation Information
Table 104. Lundbeck Description and Major Businesses
Table 105. Lundbeck Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Lundbeck Product
Table 107. Lundbeck Recent Development
Table 108. Intra-Cellular Therapies Corporation Information
Table 109. Intra-Cellular Therapies Description and Major Businesses
Table 110. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Intra-Cellular Therapies Product
Table 112. Intra-Cellular Therapies Recent Development
Table 113. Novartis Pharmaceuticals Corporation Corporation Information
Table 114. Novartis Pharmaceuticals Corporation Description and Major Businesses
Table 115. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Novartis Pharmaceuticals Corporation Product
Table 117. Novartis Pharmaceuticals Corporation Recent Development
Table 118. Noven Pharmaceuticals Corporation Information
Table 119. Noven Pharmaceuticals Description and Major Businesses
Table 120. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Noven Pharmaceuticals Product
Table 122. Noven Pharmaceuticals Recent Development
Table 123. Otsuka Corporation Information
Table 124. Otsuka Description and Major Businesses
Table 125. Otsuka Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Otsuka Product
Table 127. Otsuka Recent Development
Table 128. Pfizer Corporation Information
Table 129. Pfizer Description and Major Businesses
Table 130. Pfizer Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Pfizer Product
Table 132. Pfizer Recent Development
Table 133. Reviva Pharmaceuticals Corporation Information
Table 134. Reviva Pharmaceuticals Description and Major Businesses
Table 135. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Reviva Pharmaceuticals Product
Table 137. Reviva Pharmaceuticals Recent Development
Table 138. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2021-2026) (Million US$)
Table 139. Global Bipolar Disorder Therapeutics Drugs Production Forecast by Regions (2021-2026) (K Units)
Table 140. Global Bipolar Disorder Therapeutics Drugs Production Forecast by Type (2021-2026) (K Units)
Table 141. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2021-2026) (Million US$)
Table 142. North America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions (2021-2026) (K Units)
Table 143. Europe Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions (2021-2026) (K Units)
Table 144. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions (2021-2026) (K Units)
Table 145. Latin America Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions (2021-2026) (K Units)
Table 146. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Forecast by Regions (2021-2026) (K Units)
Table 147. Bipolar Disorder Therapeutics Drugs Distributors List
Table 148. Bipolar Disorder Therapeutics Drugs Customers List
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture
Figure 2. Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type in 2020 & 2026
Figure 3. Olanzapine (Zyprexa) Product Picture
Figure 4. Quetiapine (Seroquel) Product Picture
Figure 5. Risperidone (Risperdal) Product Picture
Figure 6. Ariprazole (Abilify) Product Picture
Figure 7. Ziprasidone (Geodon) Product Picture
Figure 8. Clozapine (Clozaril) Product Picture
Figure 9. Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2020 & 2026
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Bipolar Disorder Therapeutics Drugs Report Years Considered
Figure 13. Global Bipolar Disorder Therapeutics Drugs Revenue 2015-2026 (Million US$)
Figure 14. Global Bipolar Disorder Therapeutics Drugs Production Capacity 2015-2026 (K Units)
Figure 15. Global Bipolar Disorder Therapeutics Drugs Production 2015-2026 (K Units)
Figure 16. Global Bipolar Disorder Therapeutics Drugs Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 17. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Bipolar Disorder Therapeutics Drugs Production Share by Manufacturers in 2015
Figure 19. The Top 10 and Top 5 Players Market Share by Bipolar Disorder Therapeutics Drugs Revenue in 2019
Figure 20. Global Bipolar Disorder Therapeutics Drugs Production Market Share by Region (2015-2020)
Figure 21. Bipolar Disorder Therapeutics Drugs Production Growth Rate in North America (2015-2020) (K Units)
Figure 22. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 23. Bipolar Disorder Therapeutics Drugs Production Growth Rate in Europe (2015-2020) (K Units)
Figure 24. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 25. Bipolar Disorder Therapeutics Drugs Production Growth Rate in China (2015-2020) (K Units)
Figure 26. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 27. Bipolar Disorder Therapeutics Drugs Production Growth Rate in Japan (2015-2020) (K Units)
Figure 28. Bipolar Disorder Therapeutics Drugs Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 29. Global Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions 2015-2020
Figure 30. North America Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. North America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2019
Figure 32. North America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2019
Figure 33. U.S. Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Canada Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2019
Figure 37. Europe Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2019
Figure 38. Germany Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. France Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. U.K. Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Italy Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Russia Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (K Units)
Figure 44. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2019
Figure 45. Asia Pacific Bipolar Disorder Therapeutics Drugs Consumption Market Share by Regions in 2019
Figure 46. China Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Japan Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. India Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Australia Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Thailand Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Malaysia Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Philippines Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Vietnam Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Latin America Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (K Units)
Figure 58. Latin America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2019
Figure 59. Latin America Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2019
Figure 60. Mexico Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Brazil Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Argentina Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (K Units)
Figure 64. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Market Share by Application in 2019
Figure 65. Middle East and Africa Bipolar Disorder Therapeutics Drugs Consumption Market Share by Countries in 2019
Figure 66. Turkey Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Saudi Arabia Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. U.A.E Bipolar Disorder Therapeutics Drugs Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type (2015-2020)
Figure 70. Global Bipolar Disorder Therapeutics Drugs Production Market Share by Type in 2019
Figure 71. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2015-2020)
Figure 72. Global Bipolar Disorder Therapeutics Drugs Reven

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Divalproex Sodium Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81

Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......

Global Divalproex Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......

Global Quetiapine Fumarate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......

Global Clozapine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Trazodone Hydrochloride (API) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92

According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......

Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93

According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......

Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......

Global Risperidone Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......

Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028

Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101

Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs